The recall response induced by genital challenge with Chlamydia muridarum protects the oviduct from pathology but not from reinfection

Infection and Immunity

Volumn 80, Issue 6, 2012, Pages 2194-2203

  Riley, Melissa M ^a   Zurenski, Matthew A ^a   Frazer, Lauren C ^a   O'Connell, Catherine M ^a   Andrews, Charles W ^b   Mintus, Margaret ^a   Darville, Toni ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b Milstead Pathology Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; BACTERIAL VACCINE; LIVE VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BACTERIAL STRAIN; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHLAMYDIA; CHLAMYDIASIS; CONTROLLED STUDY; FEMALE; INOCULATION; LEUKOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; OVIDUCT; PATHOLOGY; PRIORITY JOURNAL; REINFECTION; TH1 CELL; ANIMAL; C3H MOUSE; CYTOLOGY; GYNECOLOGIC DISEASE; IMMUNOLOGY; INFLAMMATION; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; PREGNANCY; TIME;

ANIMALS; BACTERIAL VACCINES; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; FEMALE; GENITAL DISEASES, FEMALE; INFLAMMATION; LEUKOCYTES; MICE; MICE, INBRED C3H; OVIDUCTS; PREGNANCY; TH1 CELLS; TIME FACTORS; VACCINES, ATTENUATED;

EID: 85047688155     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00169-12     Document Type: Article

References (38)

1. Bakken IJ, Skjeldestad FE, Nordbo SA. 2007. Chlamydia trachomatis infections increase the risk for ectopic pregnancy: a population-based, nested case-control study. Sex. Transm. Dis. 34:166 -169.
2. Batteiger BE, et al. 2010. Repeated Chlamydia trachomatis genital infections in adolescent women. J. Infect. Dis. 201:42-51.
3. Brunham RC, Pourbohloul B, Mak S, White R, Rekart ML. 2005. The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection. J. Infect. Dis. 192:1836 -1844.
4. Brunham RC, Pourbohloul B, Mak S, White R, Rekart ML. 2006. Reply to Hagdu and to Moss et al. J. Infect. Dis. 193:1338 -1339.
5. Cohen CR, et al. 2000. Human immunodeficiency virus type 1-infected women exhibit reduced interferon-gamma secretion after Chlamydia trachomatis stimulation of peripheral blood lymphocytes. J. Infect. Dis. 182: 1672-1677.
6. Darville T, et al. 1997. Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response. Infect. Immun. 65:3065-3073.
7. Ely KH, Roberts AD, Woodland DL. 2003. Cutting edge: effector memory CD8+T cells in the lung airways retain the potential to mediate recall responses. J. Immunol. 171:3338 -3342.
8. Hillis SD, Owens LM, Marchbanks PA, Amsterdam LE, MacKenzie WR. 1997. Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. Am. J. Obstet. Gynecol. 176:103-107.
9. Hvid M, et al. 2007. Interleukin-1 is the initiator of fallopian tube destruction during Chlamydia trachomatis infection. Cell Microbiol. 9:2795-2803.
10. Igietseme JU, et al. 1993. Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific TH1 lymphocyte clone. Regional Immunol. 5:317-324.
11. Igietseme JU, Rank RG. 1991. Susceptibility to reinfection after a primary chlamydial genital infection is associated with a decrease of antigenspecific T cells in the genital tract. Infect. Immun. 59:1346 -1351.
12. Johnson AP, Hetherington CM, Osborn MF, Thomas BJ, Taylor-Robinson D. 1980. Experimental infection of the marmoset genital tract with Chlamydia trachomatis. Br. J. Exp. Pathol. 61:291-295.
13. Kari L, et al. 2011. A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates. J. Exp. Med. 208:2217-2223.
14. Kelly KA, Robinson EA, Rank RG. 1996. Initial route of antigen administration alters the T-cell cytokine profile produced in response to the mouse pneumonitis biovar of Chlamydia trachomatis following genital infection. Infect. Immun. 64:4976-4983. (Erratum, 65:2508, 1997.)
15. Kimani J, et al. 1996. Risk factors for Chlamydia trachomatis pelvic inflammatory disease among sex workers in Nairobi, Kenya. J. Infect. Dis. 173:1437-1444.
16. Lampe MF, Wilson CB, Bevan MJ, Starnbach MN. 1998. Gamma interferon production by cytotoxic T lymphocytes is required for resolution of Chlamydia trachomatis infection. Infect. Immun. 66:5457-5461.
17. Morrison RP, Caldwell HD. 2002. Immunity to murine chlamydial genital infection. Infect. Immun. 70:2741-2751.
18. Moss NJ, Ahrens K, Kent CK, Klausner JD. 2006. The decline in clinical sequelae of genital Chlamydia trachomatis infection supports current control strategies. J. Infect. Dis. 193:1336 -1338.
19. Murthy AK, et al. 2011. TNF-alpha production from CD8+ T cells mediates oviduct pathological sequelae following primary genital Chlamydia muridarum infection. Infect. Immun. 79:2928 -2935.
20. O'Connell CM, et al. 2011. Toll-like receptor 2 activation by Chlamydia trachomatis is plasmid dependent, and plasmid-responsive chromosomal loci are coordinately regulated in response to glucose limitation by C. trachomatis but not by C. muridarum. Infect. Immun. 79:1044 -1056.
21. O'Connell CM, Ingalls RR, Andrews CW, Jr, Skurlock AM, Darville T. 2007. Plasmid-deficient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease. J. Immunol. 179:4027- 4034.
22. O'Connell CM, Nicks KM. 2006. A plasmid-cured Chlamydia muridarum strain displays altered plaque morphology and reduced infectivity in cell culture. Microbiology 152:1601-1607.
23. Patton DL, Wolner-Hanssen P, Cosgrove SJ, Holmes KK. 1990. The effects of Chlamydia trachomatis on the female reproductive tract of the Macaca nemestrina after a single tubal challenge following repeated cervical inoculations. Obstet. Gynecol. 76:643- 650.
24. Ramsey KH, Rank RG. 1991. Resolution of chlamydial genital infection with antigen-specific T-lymphocyte lines. Infect. Immun. 59:925-931.
25. Rank RG, Batteiger BE, Soderberg LS. 1988. Susceptibility to reinfection after a primary chlamydial genital infection. Infect. Immun. 56:2243- 2249.
26. Rank RG, Bowlin AK, Kelly KA. 2000. Characterization of lymphocyte response in the female genital tract during ascending chlamydial genital infection in the guinea pig model. Infect. Immun. 68:5293-5298.
27. Rank RG, Ramsey KH, Pack EA, Williams DM. 1992. Effect of gamma interferon on resolution of murine chlamydial genital infection. Infect. Immun. 60:4427- 4429.
28. Rank RG, Sanders MM, Patton DL. 1995. Increased incidence of oviduct pathology in the guinea pig after repeat vaginal inoculation with the chlamydial agent of guinea pig inclusion conjunctivitis. J. Sex. Transm. Dis. 22:48 -54.
29. Roberts AD, Woodland DL. 2004. Cutting edge: effector memory CD8+ T cells play a prominent role in recall responses to secondary viral infection in the lung. J. Immunol. 172:6533- 6537.
30. Shah AA, et al. 2005. Histopathologic changes related to fibrotic oviduct occlusion after genital tract infection of mice with Chlamydia muridarum. Sex. Transm. Dis. 32:49 -56.
31. Stephens R, Langhorne J. 2010. Effector memory Th1 CD4 T cells are maintained in a mouse model of chronic malaria. PLoS Pathog. 6:e1001208.
32. Su H, Messer R, Whitmire W, Hughes S, Caldwell HD. 2000. Subclinical chlamydial infection of the female mouse genital tract generates a potent protective immune response: implications for development of live attenuated chlamydial vaccine strains. Infect. Immun. 68:192-196.
33. Su H, et al. 1999. The effect of doxycycline treatment on the development of protective immunity in a murine model of chlamydial genital infection. J. Infect. Dis. 180:1252-1258.
34. Van Voorhis WC, Barrett LK, Sweeney YT, Kuo CC, Patton DL. 1997. Repeated Chlamydia trachomatis infection of Macaca nemestrina fallopian tubes produces a Th1-like cytokine response associated with fibrosis and scarring. Infect. Immun. 65:2175-2182.
35. Vickers DM, Osgood ND. 2010. Current crisis or artifact of surveillance: insights into rebound chlamydia rates from dynamic modelling. BMC Infect. Dis. 10:70. doi:doi:10.1186/1471-2334-10-70.
36. Wang SP, Grayston JT, Alexander ER. 1967. Trachoma vaccine studies in monkeys. Am. J. Ophthalmol. 63(Suppl.):30.
37. Wolner-Hanssen P, Patton DL, Holmes KK. 1991. Protective immunity in pig-tailed macaques after cervical infection with Chlamydia trachomatis. Sex. Transm. Dis. 18:21-25.
38. Woolridge RL, Grayston JT, Chang IH, Yang CY, Cheng KH. 1967. Long-term follow-up of the initial (1959 -1960) trachoma vaccine field trial on Taiwan. Am. J. Ophthalmol. 63(Suppl.):5.